13F Filings History of SANDERS MORRIS HARRIS LLC

Latest 13F report
Q4 2025 - 08 Jan 2026
Value $
$64,718,978
Signature - Title
David Block - OSJ Supervisor
Location
Houston, TX
Summary
This page shows a list of all the recent 13F filings made by SANDERS MORRIS HARRIS LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. SANDERS MORRIS HARRIS LLC reported 35 stock holdings with total value $64,718,978 as of Q4 2025. Top holdings included QQQ, VOXR, BABA, JBS, and SLB.

Notify me when SANDERS MORRIS HARRIS LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 35 $64,718,978 +$5,205,473 -$699,760,238 -$694,554,765 QQQ, VOXR, BABA, JBS, SLB 13F-HR 08 Jan 2026, 09:08
Q3 2025 307 $751,440,745 +$330,747,288 -$25,740,412 +$305,006,876 QQQ, BX, NVDA, CSWC, AAPL 13F-HR 06 Oct 2025, 20:29
Q2 2025 162 $418,659,434 +$36,778,360 -$307,846,605 -$271,068,245 QQQ, BX, CSWC, EPD, MSIF 13F-HR 30 Jul 2025, 11:43
Q1 2025 288 $647,420,532 +$84,393,545 -$58,485,618 +$25,907,927 QQQ, BX, CSWC, EPD, AAPL 13F-HR 08 Apr 2025, 20:17
Q4 2024 291 $669,897,197 +$91,388,190 -$46,139,776 +$45,248,414 QQQ, BX, AAPL, EPD, NVDA 13F-HR 14 Jan 2025, 19:55
Q3 2024 287 $602,897,715 +$42,523,478 -$72,561,903 -$30,038,425 QQQ, BX, AAPL, NVDA, EPD 13F-HR 08 Oct 2024, 17:57
Q2 2024 289 $609,041,833 +$109,610,883 -$11,339,490 +$98,271,393 QQQ, BX, AAPL, NVDA, CSWC 13F-HR 12 Jul 2024, 13:56
Q1 2024 276 $515,580,468 +$321,149,085 -$137,329,416 +$183,819,669 QQQ, BX, AAPL, NVDA, CSWC 13F-HR 11 Apr 2024, 10:07
Q4 2023 162 $202,849,256 +$26,001,683 -$357,345,719 -$331,344,036 AAPL, NVDA, CTAS, SPY, RSP 13F-HR 10 Jan 2024, 15:01
Q3 2023 256 $486,844,270 +$57,555,967 -$20,340,295 +$37,215,672 QQQ, BX, AAPL, EPD, CSWC Restatement 13 Oct 2023, 10:27
Q2 2023 253 $451,664,552 +$158,179,314 -$15,124,221 +$143,055,093 QQQ, BX, AAPL, EPD, CSWC 13F-HR 10 Jul 2023, 21:26
Q1 2023 142 $286,209,589 +$132,301,758 -$126,113,865 +$6,187,893 QQQ, BX, EPD, CSWC, ELAN 13F-HR 07 Apr 2023, 13:20
Q4 2022 208 $264,134,567 +$7,788,959 -$160,271,660 -$152,482,701 BX, AAPL, EPD, CSWC, ELAN 13F-HR 12 Jan 2023, 21:20
Q3 2022 292 $407,759,000 +$78,978,105 -$103,522,783 -$24,544,678 QQQ, BX, AAPL, EPD, CSWC 13F-HR 07 Oct 2022, 16:10
Q2 2022 288 $457,091,000 +$82,173,176 -$40,850,546 +$41,322,630 QQQ, BX, VYGG, AAPL, EPD 13F-HR 08 Jul 2022, 18:00
Q1 2022 301 $513,321,000 +$55,333,713 -$89,226,879 -$33,893,166 QQQ, BX, AAPL, CSWC, EPD 13F-HR 11 Apr 2022, 17:08
Q4 2021 336 $578,106,000 +$97,587,732 -$76,805,225 +$20,782,507 QQQ, BX, VYGG, AAPL, CSWC 13F-HR 02 Feb 2022, 16:17
Q3 2021 310 $549,551,000 +$109,066,667 -$71,353,347 +$37,713,320 QQQ, BX, VYGG, CSWC, AAPL 13F-HR 12 Oct 2021, 21:40
Q2 2021 319 $514,712,000 +$107,974,155 -$104,806,458 +$3,167,697 QQQ, BX, AAPL, VYGG, CSWC 13F-HR 13 Jul 2021, 10:37
Q1 2021 296 $472,869,000 +$86,418,131 -$77,283,125 +$9,135,006 QQQ, BX, IVV, CSWC, EPD Restatement 19 Apr 2021, 14:42
Q4 2020 293 $434,906,000 +$74,184,363 -$45,015,433 +$29,168,930 QQQ, BX, IVV, CSWC, EPD 13F-HR 25 Jan 2021, 21:24
Q3 2020 274 $363,019,000 +$176,783,416 -$21,937,229 +$154,846,187 QQQ, BX, ELAN, CSWC, EPD 13F-HR 15 Oct 2020, 18:12
Q2 2020 129 $205,526,000 +$40,279,385 -$48,282,948 -$8,003,563 QQQ, BX, EPD, CSWC, AIMT 13F-HR 08 Jul 2020, 17:42
Q1 2020 148 $51,640,000 $0 $0 $0 VZ, PG, QURE, TMO, RMD Restatement 09 Apr 2020, 17:46
Q4 2019 283 $429,690,000 +$66,198,782 -$80,865,001 -$14,666,219 QQQ, CSWC, EPD, MAIN, JPM 13F-HR 09 Jan 2020, 14:26
Q3 2019 279 $413,130,000 +$86,449,519 -$58,125,880 +$28,323,639 QQQ, CSWC, MAIN, BX, EPD 13F-HR 14 Nov 2019, 08:12
Q2 2019 273 $382,287,000 +$207,698,234 -$29,701,865 +$177,996,369 QQQ, CSWC, MAIN, EPD, BX 13F-HR 10 Jul 2019, 06:10
Q1 2019 127 $205,546,000 +$30,896,264 -$38,573,830 -$7,677,566 QQQ, CSWC, EPD, MAIN, JYNT 13F-HR 19 Apr 2019, 07:21
Q4 2018 119 $182,054,000 +$31,620,496 -$21,307,285 +$10,313,211 QQQ, CSWC, EPD, MAIN, JYNT 13F-HR 14 Jan 2019, 17:09
Q3 2018 136 $213,370,000 +$27,536,161 -$30,395,034 -$2,858,873 QQQ, EPD, MAIN, JYNT, BX Restatement 10 Oct 2018, 09:49
Q2 2018 140 $215,966,000 +$41,383,937 -$69,905,917 -$28,521,980 EPD, MAIN, QQQ, PCG, JYNT 13F-HR 10 Jul 2018, 16:18
Q1 2018 144 $238,714,000 +$47,340,161 -$39,699,234 +$7,640,927 QQQ, JYNT, EPD, MAIN, XOM 13F-HR 14 May 2018, 09:13
Q4 2017 132 $236,687,000 +$49,064,188 -$47,818,525 +$1,245,663 MAIN, EPD, XOM, QQQ, JYNT 13F-HR 15 Feb 2018, 14:57
Q3 2017 142 $234,443,000 +$48,171,557 -$57,368,926 -$9,197,369 MAIN, EPD, ECR, JYNT, KEY 13F-HR 20 Oct 2017, 17:36
Q2 2017 134 $245,331,000 +$39,982,096 -$69,235,616 -$29,253,520 MAIN, EPD, XOM, ECR, KEY 13F-HR 12 Jul 2017, 20:57
Q1 2017 146 $273,763,000 +$97,878,456 -$46,044,880 +$51,833,576 MAIN, EPD, XOM, ECR, TLGT Restatement 20 Apr 2017, 15:51
Q4 2016 133 $215,920,000 +$28,415,001 -$125,352,882 -$96,937,881 MAIN, EPD, ECR, TLGT, JYNT 13F-HR 24 Jan 2017, 14:23
Q3 2016 159 $315,681,695 +$22,555,702 -$17,233,158,208 -$17,210,602,506 MAIN, XOM, EPD, PDL BIOPHARMA INC, TLGT 13F-HR 24 Oct 2016, 16:33
Q2 2016 240 $430,046,000 +$58,916,692 -$277,271,087 -$218,354,395 MAIN, XOM, EPD, PDL BIOPHARMA INC, TLGT 13F-HR 25 Jul 2016, 07:02
Q1 2016 335 $580,995,000 $0 $0 $0 MAIN, XOM, EPD, XLV, XLP 13F-HR 27 Apr 2016, 10:44
Q4 2015 0 $0 13F-NT 16 Feb 2016, 08:55
Q3 2015 0 $0 13F-NT 30 Oct 2015, 08:37
Q2 2015 0 $0 13F-NT 28 Jul 2015, 16:56
Q1 2015 0 $0 13F-NT 19 May 2015, 15:21
Q4 2014 0 $0 13F-NT 17 Feb 2015, 20:12
Q3 2014 0 $0 13F-NT 13 Nov 2014, 15:07
Q2 2014 0 $0 13F-NT 07 Aug 2014, 21:27
Q1 2014 0 $0 13F-NT 16 May 2014, 06:36
Q4 2013 0 $0 13F-NT 11 Feb 2014, 18:51